Ethanol and Hydrazine Sulfate Induced Chronic Hepatic Injury in Rats: The Curative Effect Of Administration of Glucogenic Amino Acids

1993 ◽  
Vol 28 (Supplement_1A) ◽  
pp. 111-117 ◽  
Author(s):  
Hiroshi Suzuki ◽  
Tomoya Tominaga ◽  
Hiroshi Mizuno ◽  
Mayumi Kouno ◽  
Michihiro Suzuki ◽  
...  
1966 ◽  
Vol 22 (10) ◽  
pp. 701-702 ◽  
Author(s):  
R. Preisig ◽  
D. Gocke ◽  
T. Morris ◽  
S. E. Bradley

2018 ◽  
Vol 50 (1) ◽  
pp. 4-5
Author(s):  
M. Crescenzi ◽  
C. Frasson ◽  
M.F. Secchi ◽  
P. Burra ◽  
G. Basso ◽  
...  

2012 ◽  
Vol 16 (11) ◽  
pp. 2647-2654 ◽  
Author(s):  
Takayuki Kogure ◽  
Stefan Costinean ◽  
Irene Yan ◽  
Chiara Braconi ◽  
Carlo Croce ◽  
...  

Amino Acids ◽  
2008 ◽  
Vol 37 (2) ◽  
pp. 239-247 ◽  
Author(s):  
Torai Komano ◽  
Reiko (Yokoyama) Funakoshi ◽  
Yukari Egashira ◽  
Hiroo Sanada

2020 ◽  
Vol 2020 ◽  
pp. 1-14
Author(s):  
Li Wang ◽  
Huantian Cui ◽  
Yuting Li ◽  
Min Cao ◽  
Shanshan Man ◽  
...  

Kang-Xian (KX) pills have been clinically used for the treatment of chronic hepatic injury (CHI). However, the mechanisms of KX on CHI remain unknown. The aim of this study mainly focused on the anti-inflammatory effects of KX in a CHI mouse model based on modulating gut microbiota and gut permeability. We first established a CHI model using carbon tetrachloride (CCl4) and treated it with KX. The anti-inflammatory effects of KX on CHI model mice and the changes in gut permeability after KX treatment were also investigated. 16S rRNA analysis was used to study the changes of gut microbiota composition after KX treatment. In addition, gut microbiota was depleted using a combination of antibiotics in order to further confirm that KX could inhibit the inflammatory response and decrease gut permeability to treat CHI by modulating the gut microbiota. Results showed that KX treatment significantly improved liver function in CHI model mice. KX could also increase the levels of tight junction proteins in the colon and decrease the expression of proinflammatory cytokines in the liver. 16S rRNA analysis indicated that KX treatment affected the alpha and beta diversities in CHI model mice. Further analysis of 16S rRNA sequencing indicated that KX treatment increased the ratio of Firmicutes to Bacteroidetes at the phylum level. At the genus level, KX treatment increased the relative abundance of Lactobacillus, Bacteroides, and Akkermansia and decreased the relative abundance of Ralstonia, Alloprevotella, and Lachnoclostridium. However, KX could not alleviate CHI after depleting the gut microbiota. The effects of KX on gut permeability and inflammatory response in the liver were also decreased following the depletion of gut microbiota. In conclusion, our current study demonstrated that gut microbiota was significantly affected during CHI progression. KX could inhibit the inflammatory response and decrease the gut permeability in CHI model mice through modulating the gut microbiota.


Author(s):  
Lisha Chen ◽  
Yan Huang ◽  
Zhixi Duan ◽  
Peiqi Huang ◽  
Hongbing Yao ◽  
...  

Liver fibrosis is an outcome of chronic hepatic injury, which can eventually result in cirrhosis, liver failure, and even liver cancer. The activation of hepatic stellate cell (HSC) is a prominent driver of liver fibrosis. Recently, it has been found that the crosstalk between HSCs and immune cells, including hepatic macrophages, plays an important role in the initiation and development of liver fibrosis. As a vital vehicle of intercellular communication, exosomes transfer specific cargos into HSCs from macrophages. Here, we show that exosomes derived from lipopolysaccharide (LPS)-treated macrophages has higher expression level of miR-500. And overexpression or inhibition of miR-500 in macrophage exosomes could promote or suppress HSC proliferation and activation. Treatment of exosomes with miR-500 overexpression can accelerate liver fibrosis in CCl4-induced liver fibrosis mouse model. miR-500 promotes HSC activation and liver fibrosis via suppressing MFN2. Moreover, miR-500 in serum exosomes could be a biomarker for liver fibrosis. Taken together, exosomal miR-500 derived from LPS-activated macrophages promotes HSC proliferation and activation by targeting MFN2 in liver fibrosis.


2008 ◽  
Vol 146 (1-3) ◽  
pp. 73-79 ◽  
Author(s):  
Sevgin Özlem İşeri ◽  
Göksel Şener ◽  
Beyhan Saglam ◽  
Feriha Ercan ◽  
Nursal Gedik ◽  
...  

1949 ◽  
Vol 89 (2) ◽  
pp. 245-268 ◽  
Author(s):  
Paul György ◽  
Harry Goldblatt

The present report on experimental hepatic injury is based on observations amassed during the last 9 years, comprising 1922 rats. It has been shown that there are several dietary factors which may intervene, singly or in combination, in the development of massive or zonal hepatic necrosis. Deficiency of sulfur-containing amino acids is only one of them. From the present studies, tocopherol emerges as an additional protective dietary factor. With regard to the development of massive hepatic necrosis tocopherol may compensate for the absence of sulfur-containing amino acids (cystine, methionine) and vice versa. As a further factor, the quality of dietary fat should be taken into consideration. Fats, like lard and cod liver oil, with a high content of unsaturated fatty acids enhance, whereas fats low in unsaturated fatty acids, such as crisco and butter, retard or prevent the development of massive hepatic necrosis. It is questionable whether with all these dietary factors the etiology of massive hepatic necrosis is completely defined. The interchangeability of sulfur-containing amino acids (cystine, methionine) and vitamin E as leading etiologic factors makes it difficult to accept pure deficiency as the basis of massive hepatic necrosis. The rôle of possible endogenous hepatotoxic substances and their neutralization by cystine (methionine) or tocopherol are discussed. Diffuse hepatic fibrosis is a regular occurrence in rats kept for 100 to 150 days on a diet low in lipotropic factors. Cystine, and, among the fats, lard and especially cod liver oil, have an enhancing effect on the production of hepatic cirrhosis. In rats fed rations free from cod liver oil, and with vegetable shortening such as crisco as source of fat, the incidence and severity of cirrhosis are reduced. Ceroid deposit accompanies cirrhosis only in rats which have been kept on a cirrhosis-producing diet containing fats with a high content of unsaturated fatty acids (cod liver oil, lard). Tocopherol, even when given in excessively large doses (30 mg. daily) will not prevent the formation of ceroid, and will reduce only slightly its total quantity. Under the same treatment the incidence and intensity of cirrhosis remain uninfluenced. Cellular injury in the form of degenerated or necrotic hepatic parenchymal cells, found singly or in small groups in and around the fibrous bands in the cirrhotic liver of rats, is a common occurrence. The fibrotic changes seem to begin, not in the portal spaces, but close to the central vein, although they are not as distinctly and exclusively pericentral as, for instance, in cardiac cirrhosis. Thus, experimental dietary cirrhosis is non-portal. The role of fat infiltration is discussed with special reference to the other microscopic changes found in hepatic cirrhosis. Acute necrotizing nephrosis or various stages of healing of this process are often found with great frequency in rats kept on a cirrhosis-producing diet.


Sign in / Sign up

Export Citation Format

Share Document